Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Compugen (CGEN) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Compugen (CGEN) over the last 15 years, with Q2 2025 value amounting to $160.0.

  • Compugen's Shares Outstanding (Weighted Average) rose 6000.0% to $160.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $160.0, marking a year-over-year increase of 6000.0%. This contributed to the annual value of $88.4 million for FY2023, which is 206.72% up from last year.
  • Compugen's Shares Outstanding (Weighted Average) amounted to $160.0 in Q2 2025, which was up 6000.0% from $92.3 million recorded in Q1 2025.
  • Compugen's 5-year Shares Outstanding (Weighted Average) high stood at $92.3 million for Q1 2025, and its period low was $100.0 during Q2 2024.
  • Over the past 5 years, Compugen's median Shares Outstanding (Weighted Average) value was $86.5 million (recorded in 2022), while the average stood at $58.2 million.
  • In the last 5 years, Compugen's Shares Outstanding (Weighted Average) plummeted by 5238.1% in 2024 and then soared by 6000.0% in 2025.
  • Quarter analysis of 5 years shows Compugen's Shares Outstanding (Weighted Average) stood at $84.0 million in 2021, then grew by 3.15% to $86.6 million in 2022, then rose by 2.07% to $88.4 million in 2023, then tumbled by 100.0% to $100.0 in 2024, then skyrocketed by 60.0% to $160.0 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $160.0 for Q2 2025, versus $92.3 million for Q1 2025 and $100.0 for Q2 2024.